4basebio PLC, a gene therapy company, is aiming to revolutionize the field’s technology and solutions. Their primary focus has been to create synthetic DNA, which offers numerous benefits such as higher safety, efficacy, and cost-saving in comparison to plasmid DNA. The company's near-term goal is to develop Good Manufacturing Practice (GMP) grade synthetic DNA, a crucial milestone in the commercialization of their core technology.
4basebio PLC's ticker is 4BB
The company's shares trade on the LSE stock exchange
They are based in Cambridge, England
There are 11-50 employees working at 4basebio PLC
It is https://www.4basebio.com/
4basebio PLC is in the Healthcare sector
4basebio PLC is in the Biotechnology industry
The following five companies are 4basebio PLC's industry peers: